Is CVM (CVM) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 28.2% / 30% | 32.9% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 28.2% / 33% | 32.9% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| MSCI | 33.3% / 33% | 38.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 28.2% / 33% | 32.9% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| FTSE | 33.3% / 33% | 38.9% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -212.1% | |
| Return on Assets (ROA) | -59.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$17M |
| Free Cash Flow | -$17M |
| Total Debt | $9M |
| Debt-to-Equity | 81.7 |
| Current Ratio | 1.4 |
| Total Assets | $28M |
Price & Trading
| Last Close | $3.47 |
| 50-Day MA | $4.56 |
| 200-Day MA | $6.40 |
| Avg Volume | 58K |
| Beta | 0.9 |
|
52-Week Range
$1.98
| |
About CVM (CVM)
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CVM (CVM) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CVM is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CVM's debt ratio?
CVM's debt ratio is 28.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 33.3%.
What are CVM's key financial metrics?
CVM has a market capitalization of $27M. Return on equity stands at -212.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.